Additively manufactured medical products – the FDA perspective

Additive manufacturing/3D printing of medical devices is becoming more commonplace, a 3D printed drug is now commercially available, and bioprinting is poised to transition from laboratory to market. Despite the variety of technologies enabling these products, the US Food and Drug Administration (FD...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Prima, Matthew, Coburn, James, Hwang, David, Kelly, Jennifer, Khairuzzaman, Akm, Ricles, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027614/
https://www.ncbi.nlm.nih.gov/pubmed/29974058
http://dx.doi.org/10.1186/s41205-016-0005-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027614/
https://www.ncbi.nlm.nih.gov/pubmed/29974058
http://dx.doi.org/10.1186/s41205-016-0005-9

Ejemplares similares